Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New inhibitors of dual specificity protein kinase TTK claimed

Oct. 19, 2010

New protein kinase inhibitors identified by sanofi-aventis

Oct. 19, 2010

EC grants orphan drug status for pralatrexate in Hodgkin's lymphoma

Oct. 19, 2010

U.S. scientists claim new MAPK 8 inhibitors

Oct. 19, 2010

PharmaGap reports initial preclinical toxicity data on GAP-107B8

Oct. 18, 2010

MRC Technology describes new protein kinase inhibitors

Oct. 18, 2010

New HSP 90 inhibitors identified at sanofi-aventis

Oct. 18, 2010

BioLineRx acquires rights to Santhera's melanocortin MC4 receptor antagonists for cachexia

Oct. 18, 2010

FDA funds phase I trial of genetically reprogrammed HSV in childhood cancer

Oct. 15, 2010

French scientists claim new inhibitors of cell division protein kinases

Oct. 15, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...